Did You Know?

Did you know that a single FDA device reclassification could save the medical device industry millions of dollars?

Oct 06, 2010 | Free Downloads | email | Print

Share This Article

All medical device manufacturers know the implications of the Class I, II and III device categories. If a device falls in the Class I category then the probable mantra is "Full steam ahead! Piece of cake!" Perhaps this "mantra" seems exaggerated but in comparison to Class II stipulations, Class I requirements do seem relatively simple.

And Class III? Class III devices—for good reason—require a PMA (Pre-Market Approval) which is not easy to obtain without significant expenditure on the part of the manufacturer. For this reason, it is significant that the FDA has redefined standard percutaneous transluminal coronary angioplasty catheters as Class II devices instead of Class III devices. As Class II devices these catheter types will still require "special controls" as reported by FDANews but will still save manufacturers thousands, hundreds of thousands and perhaps millions of dollars under the auspices of Class II requirements.

On October 8, 2010 the final rule regarding the reclassification will be officially released and regarded as effective.

Share This Article

Watch Related Videos

Download Free Resources
White Paper: Engineering and Quality Teams in Medical Device Firms: Can We All Get Along?
White Paper: ISO 15189 Standards: For Medical and Clinical Laboratories
Analyst Report: Risk Management: Best Practices for Medical Device Profitability
White Paper: Drug and Device Accountability Act of 2008: How Execs can Avoid Jail Time
Product Data Sheet: MasterControl Not-for-Profit Pricing